MX9704594A - Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina. - Google Patents

Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina.

Info

Publication number
MX9704594A
MX9704594A MX9704594A MX9704594A MX9704594A MX 9704594 A MX9704594 A MX 9704594A MX 9704594 A MX9704594 A MX 9704594A MX 9704594 A MX9704594 A MX 9704594A MX 9704594 A MX9704594 A MX 9704594A
Authority
MX
Mexico
Prior art keywords
compositions
compounds
treatment
thrombin inhibitors
well
Prior art date
Application number
MX9704594A
Other languages
English (en)
Other versions
MXPA97004594A (es
Inventor
John Gillard
John Dimaio
M Arshad Siddiqui
Patrice Preville
Dominique Lafleur
Jeremy John Edmonds
Annette Marian Doherty
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9426038.7A external-priority patent/GB9426038D0/en
Priority claimed from GBGB9504403.8A external-priority patent/GB9504403D0/en
Priority claimed from GBGB9504404.6A external-priority patent/GB9504404D0/en
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of MX9704594A publication Critical patent/MX9704594A/es
Publication of MXPA97004594A publication Critical patent/MXPA97004594A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invencion se refiere a nuevos y utiles inhibidores de la enzima trombina de la formula (I): AS -X, y, más particularmente, el compuesto (1), en la preparacion, y a composiciones farmacéuticas. Igualmente, esta invencion se refiere al uso de tales compuestos y composiciones in vitro, como anticoagulantes e in vivo como agentes para el tratamiento venosa, embolismo pulmonar y trombosis arterial, que resulta en eventos isquémicos agudos, tal como el infarto al miocardio o infarto cerebral. Asimismo, estos compuestos y composiciones tienen utilidad terapéutica para la prevencion y tratamiento de coagulopatías asociadas con operaciones de puentes coronarios, al igual que eventos restenoticos que siguen a la angioplastia transluminal.
MXPA/A/1997/004594A 1994-12-22 1997-06-19 Peptidos heterociclicos de la ceto-arginina, comoinhibidores de la trombina MXPA97004594A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9426038.7 1994-12-22
GBGB9426038.7A GB9426038D0 (en) 1994-12-22 1994-12-22 Low molecular weight bicyclic thrombin inhibitors
GBGB9503136.5A GB9503136D0 (en) 1994-12-22 1995-02-17 Low molecular weight bicyclic thrombin inhibitors
GB9503136.5 1995-02-17
GB9504403.8 1995-03-06
GB9504404.6 1995-03-06
GBGB9504403.8A GB9504403D0 (en) 1995-03-06 1995-03-06 Heterocyclic keto arginine peptides as thrombin inhibitors
GBGB9504404.6A GB9504404D0 (en) 1995-03-06 1995-03-06 Heterocyclic keto arginine peptides as thrombin inhibitors

Publications (2)

Publication Number Publication Date
MX9704594A true MX9704594A (es) 1998-07-31
MXPA97004594A MXPA97004594A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
AU4250896A (en) 1996-07-10
JPH10513151A (ja) 1998-12-15
CA2208773A1 (en) 1996-06-27
AU699679B2 (en) 1998-12-10
IL116502A0 (en) 1996-03-31
AU4062795A (en) 1996-06-27
EP0799240A1 (en) 1997-10-08
WO1996019491A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
AP9701004A0 (en) Low molecular weight bicyclic thrombin inhibitors.
WO2001064643A3 (en) Benzamides and related inhibitors of factor xa
DE69824037D1 (de) Beta-alanin-derivate als zell-adhäsions-inhibitoren
IL108944A0 (en) Phenoxyphenylacetic acid derivatives and pharmaceutical compositions containing them
DE69324151D1 (de) Inhibitoren des arginin-ketoamid-enzyms
Bane Jr et al. Factor XI as a target for antithrombotic therapy
ATE318841T1 (de) Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
AU3664401A (en) Platelet adp receptor inhibitors
BG105880A (en) Compounds useful as anti-inflammatory agents
ATE204583T1 (de) Menschliche monocyte chemoattractantia proteine-1 (mcp) derivaten
CA2180954A1 (en) Inhibitors of human plasmin derived from the kunitz domains
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
HUP0303665A2 (hu) Káliumcsatorna-blokkoló hatású arilezett furán- és tiofén-karbonsavamidok
SG50602A1 (en) Novel heterocyclic compound
WO2000071516A3 (en) INHIBITORS OF FACTOR Xa
UA70919C2 (uk) Композиція для лікування та запобігання артеріальному тромбозу з використанням інгібітора фактора ха окремо або в комбінації з препаратом, що унеможливлює агрегацію тромбоцитів
WO2000040583A3 (de) Imidazo[4,5-c]-pyridin-4-on-derivate
TW369541B (en) Thrombin inhibitors
MX9704594A (es) Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina.
NO943126D0 (no) 3-alkyloksy-, aryloksy- eller arylalkyloksybenzo-[bÅtiofen-2-karboksamider som hemmere av celleadhesjon
WO2002026718A3 (en) Bicyclic pyrimidin-4-one based inhibitors of factor xa
NZ334438A (en) (S)-7-[(4,4'-bipiperidrin-1-yl)carbonyl]-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetic acid hydrochloride as a platelet aggregation inhibitor
WO2002026731A3 (en) Quaternary amidino based inhibitors of factor xa
UA35554C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти у вигляді суміші ізомерів або окремих ізомерів, фармацевтична композиція, що має антибактеріальну активність та проміжні сполуки
EP0202084A3 (en) Fluoroalkane derivatives